Guangdong Xinyaguang Cable
001382
Haimo Technologies Group Corp.
300084
Shaoyang Victor Hydraulics
301079
4
KLT
831689
5
Qingdao Tianneng Heavy Industries
300569
US Stock MarketDetailed Quotes
ARTV Artiva Biotherapeutics
- 4.270
- +0.230+5.69%
Close Mar 21 16:00 ET
- 4.270
- 0.0000.00%
Post 16:20 ET
103.72MMarket Cap-1.69P/E (TTM)
4.750High3.640Low662.71KVolume4.020Open4.040Pre Close2.83MTurnover15.33%Turnover RatioLossP/E (Static)24.29MShares17.31052wk High0.52P/B18.46MFloat Cap3.37052wk Low--Dividend TTM4.32MShs Float17.310Historical High--Div YieldTTM27.48%Amplitude3.370Historical Low4.276Avg Price1Lot Size
Artiva Biotherapeutics News
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aslan Fred
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Raymon Heather
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graef Thorsten
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horan Christopher
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bush Jennifer
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnamohan Neha
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Baker Daniel G.
Artiva Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director Baker Daniel G.
Artiva Biotherapeutics | 8-K: Current report
Artiva Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%), etc.
Artiva Biotherapeutics | 10-Q: Quarterly report
Artiva Biotherapeutics | 8-K: Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOORE ALISON
Artiva Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director MOORE ALISON
Artiva Biotherapeutics | 8-K: Current report
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Raymon Heather
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graef Thorsten
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horan Christopher
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bush Jennifer
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krishnamohan Neha
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings